C-kit protein expression in tumor specimens as a predictor of sensitivity to imatinib mesylate in patients with small cell lung cancer (SCLC): A phase II clinical trial

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7218-7218 ◽  
Author(s):  
L. M. Krug ◽  
J. P. Crapanzano ◽  
V. A. Miller ◽  
C. G. Azzoli ◽  
N. Rizvi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Protein Expression ◽  
Small Cell Lung Cancer ◽  
Imatinib Mesylate ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Ii Clinical Trial ◽  
Small Cell Lung

Phase II clinical trial of didemnin B in previously treated small cell lung cancer

1994 ◽  
Vol 12 (3) ◽  
pp. 243-249 ◽  
Author(s):  
Dong M. Shin ◽  
Paul Y. Holoye ◽  
Arthur Forman ◽  
Rodger Winn ◽  
Roman Perez-Soler ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Ii Clinical Trial ◽  
Didemnin B ◽  
Small Cell Lung ◽  
Previously Treated

Phase II Clinical Trial of Lobaplatin (D-19466) in Pretreated Patients with Small-Cell Lung Cancer

1996 ◽  
Vol 19 (4) ◽  
pp. 328-332 ◽  
Author(s):  
H.H. Fiebig ◽  
H. Henß ◽  
I. von Pawel ◽  
U. Gatzemeier ◽  
Ch. Manegold ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Ii Clinical Trial ◽  
Small Cell Lung ◽  
Pretreated Patients
Sign in / Sign up

Export Citation Format

Share Document